BioStar Capital β Full Portfolio
6 tracked investments Β· listed companies and verified rows first
AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.
BiotechDeep TechHealthtechMedical DevicesAnn Arbor, US
Robert Chisena, Ph.D.(Co-Founder & Chief Technology Officer)Hitinder Gurm, M.D.(Chief Clinical Officer)
Co-investorsCorewell Health VenturesID Ventures
MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.
HealthtechMedical DevicesRoboticsJacksonville, US
Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)
Co-investorsAndera PartnersDeerfield Management CompanyFidelity InvestmentsRA CapitalCorewell Health VenturesFountain Healthcare Partners
XLerateHealth supports healthcare innovation by providing resources and mentorship to startups in the sector, with a focus on regional development in the Midwest and Southeast.
BiotechDigital HealthEnterprise SoftwareHealthtechSector AgnosticLouisville, US
Bob Saunders(Chairman & Co-founder)inTed Smith(Co-founder)Jackie Willmot(CEO & Co-founder)Bobby Ferreri
Co-investorsChrysalis VenturesOCA VenturesRender Capital
Nectero Therapeutics develops therapeutic devices for vascular medicine, working with key opinion leaders in the field.
BiotechHealthtechMedical DevicesDover, US
Jack Springer(President & CEO)inBruce Roberts(Director)in
Co-investorsAphelion CapitalCorewell Health VenturesNorwest Venture Partners
Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.
HealthtechMedical DevicesSanta Cruz, US
Co-investorsSanta Cruz VentureView VenturesCadence Healthcare VenturesS3 Ventures
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.